Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (202)
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
30,000
Price
$27.94
Total Value
$838.14K
Shares Held After
4,200
% of Holdings
87.7%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
30,829
Price
$27.95
Total Value
$861.74K
Shares Held After
4,371
% of Holdings
87.6%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
14,800
Price
$27.13
Total Value
$401.48K
Shares Held After
35,200
% of Holdings
29.6%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
15,800
Price
$27.13
Total Value
$428.68K
Shares Held After
34,200
% of Holdings
31.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,035
Price
$80.19
Total Value
$82.99K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
888
Price
$79.28
Total Value
$70.40K
Shares Held After
768,815
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$560.79
Total Value
$179.45K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
220
Price
$558.78
Total Value
$122.93K
Shares Held After
40,833
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
702
Price
$557.82
Total Value
$391.59K
Shares Held After
41,053
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$556.64
Total Value
$210.97K
Shares Held After
41,755
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
291
Price
$555.75
Total Value
$161.72K
Shares Held After
42,134
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,118
Price
$554.45
Total Value
$619.88K
Shares Held After
42,425
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,710
Price
$553.42
Total Value
$946.35K
Shares Held After
43,543
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,490
Price
$552.51
Total Value
$823.24K
Shares Held After
45,253
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
925
Price
$551.56
Total Value
$510.19K
Shares Held After
46,743
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
785
Price
$550.45
Total Value
$432.10K
Shares Held After
47,668
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
923
Price
$549.52
Total Value
$507.21K
Shares Held After
48,453
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
637
Price
$548.62
Total Value
$349.47K
Shares Held After
49,376
% of Holdings
1.3%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
1,100
Price
$6.13
Total Value
$6.74K
Shares Held After
1,482,587
% of Holdings
0.1%
Syndax Pharmaceuticals Inc (SNDX)
Metzger Michael A — Director
Shares
32,375
Price
$24.24
Total Value
$784.78K
Shares Held After
484,843
% of Holdings
6.3%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
14,338
Price
$2.46
Total Value
$35.27K
Shares Held After
2,698,518
% of Holdings
0.5%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.00
Total Value
$40.00K
Shares Held After
17,217
% of Holdings
12.7%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,400
Price
$0.96
Total Value
$5.21K
Shares Held After
361,985
% of Holdings
1.5%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
100
Price
$82.50
Total Value
$8.25K
Shares Held After
54,324
% of Holdings
0.2%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
15,000
Price
$85.46
Total Value
$1.28M
Shares Held After
0
% of Holdings
100.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
5,536
Price
$83.58
Total Value
$462.69K
Shares Held After
75,018
% of Holdings
6.9%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
10,111
Price
$85.42
Total Value
$863.64K
Shares Held After
3,811
% of Holdings
72.6%
IONIS PHARMACEUTICALS INC (IONS)
Kordasiewicz Holly B. — EVP, Chief Development Officer
Shares
362
Price
$84.30
Total Value
$30.52K
Shares Held After
22,096
% of Holdings
1.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
40,000
Price
$3.96
Total Value
$158.50K
Shares Held After
6,218,287
% of Holdings
0.6%
Immunome Inc. (IMNM)
Horn Kinney — CHIEF BUSINESS OFFICER
Shares
1,092
Price
$25.00
Total Value
$27.30K
Shares Held After
0
% of Holdings
100.0%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
3,702
Price
$6.41
Total Value
$23.73K
Shares Held After
1,483,687
% of Holdings
0.2%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
85,918
Price
$44.86
Total Value
$3.85M
Shares Held After
2,469,959
% of Holdings
3.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
2,200
Price
$43.59
Total Value
$95.91K
Shares Held After
151,994
% of Holdings
1.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
10,500
Price
$42.86
Total Value
$450.01K
Shares Held After
154,194
% of Holdings
6.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
32,550
Price
$42.07
Total Value
$1.37M
Shares Held After
164,694
% of Holdings
16.5%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
1,000
Price
$40.78
Total Value
$40.78K
Shares Held After
197,244
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
85,918
Price
$44.86
Total Value
$3.85M
Shares Held After
2,469,959
% of Holdings
3.4%
IDEAYA Biosciences, Inc. (IDYA)
Ruiz Briseno Andres — Chief Accounting Officer
Shares
9,550
Price
$40.01
Total Value
$382.13K
Shares Held After
26,466
% of Holdings
26.5%
Serina Therapeutics, Inc. (SER)
Brannan Stephen K. — Director
Shares
1,000
Price
$2.03
Total Value
$2.03K
Shares Held After
1,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
15,810
Price
$2.48
Total Value
$39.21K
Shares Held After
2,684,180
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
952
Price
$93.54
Total Value
$89.05K
Shares Held After
3,985
% of Holdings
19.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
19,048
Price
$93.11
Total Value
$1.77M
Shares Held After
4,937
% of Holdings
79.4%
PALISADE BIO, INC. (PALI)
Finley John David — Director
Shares
146,798
Price
$2.07
Total Value
$303.34K
Shares Held After
217,555
% of Holdings
40.3%
PALISADE BIO, INC. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
51,880
Price
$2.05
Total Value
$106.54K
Shares Held After
94,009
% of Holdings
35.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
30,000
Price
$2.03
Total Value
$61.04K
Shares Held After
416,904
% of Holdings
7.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
107,429
Price
$0.31
Total Value
$33.30K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
5,000
Price
$23.61
Total Value
$118.05K
Shares Held After
2,962
% of Holdings
62.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
11,665
Price
$23.62
Total Value
$275.53K
Shares Held After
815,054
% of Holdings
1.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
49,193
Price
$23.17
Total Value
$1.14M
Shares Held After
826,719
% of Holdings
5.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
14,844
Price
$23.62
Total Value
$350.62K
Shares Held After
1,140,150
% of Holdings
1.3%
Showing 51–100 of 202 transactions (page 2 of 5)